TARGETING THE GRM/MAPK1/ESRRG AXIS IN ENDOCRINE-RESISTANT INVASIVE LOBULAR CARCINOMA OF THE BREAST

$573,969FY2017Department of the ArmyDOD

Georgetown University, Washington DC

Investigators